Kayentao, K., Ongoiba, A., Preston, A. C., Healy, S. A., Hu, Z., Skinner, J., Doumbo, S., Wang, J., Cisse, H., Doumtabe, D.,
Traore, A., Traore, H., Djiguiba, A., Li, S., Peterson, M. E., Telscher, S., Idris, A. H., Adams, W. C., McDermott, A. B.,
Narpala, S., Lin, B. C., Serebryannyy, L., Hickman, S. P., McDougal, A. J., Vazquez, S., Reiber, M., Stein, J. A., Gall, J.
G., Carlton, K., Schwabl, P., Traore, S., Keita, M., Zéguimé, A., Ouattara, A., Doucoure, M., Dolo, A., Murphy, S. C., Neafsey,
D. E., Portugal, S., Djimdé, A., Traore, B., Seder, R. A., Crompton, P. D., & Mali Malaria mAb TrialTeam, (2024).
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria. The New England Journal of
Medicine: NEJM / Publ. by the Massachusetts Medical Society, 390(17), 1549-1559.
doi:10.1056/NEJMoa2312775.
